Growth factors for skeletal reconstruction and fracture repair

Current Opinion in Investigational Drugs

Volumn 5, Issue 4, 2004, Pages 419-423

  Oreffo, Richard O C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Bone regeneration; Fracture repair; Growth factor; Polypeptide

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CARRIER PROTEIN; CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH PROMOTOR; PLATELET DERIVED GROWTH FACTOR; PLEIOTROPHIN; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ANIMAL; BONE; DRUG EFFECT; FRACTURE HEALING; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CYTOKINES; FIBROBLAST GROWTH FACTORS; FRACTURE HEALING; GROWTH SUBSTANCES; HUMANS; PLATELET-DERIVED GROWTH FACTOR; SOMATOMEDINS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3042539594     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Jordan KM, Cooper C: Epidemiology of osteoporosis. Best Pract Res Clin Rheumatol (2002) 16(5):795-806.
2. Bianco P, Riminucci M, Gronthos S, Robey PG: Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells (2001) 19(3):180-192.
3. Bianco P, Robey PG: Stem cells in tissue engineering. Nature (2001) 414(6859):118-121.
4. Schmitt JM, Hwang K, Winn SR, Hollinger JO: Bone morphogenetic proteins: An update on basic biology and clinical relevance. J Orthop Res (1999) 17(2):269-278.
5. Rose FR, Oreffo ROC: Bone tissue engineering: Hope vs hype. Biochem Biophys Res Commun (2002) 292(1):1-7.
6. Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA: Growth factor regulation of fracture repair. J Bone Miner Res (1999) 14(11):1805-1815.
7. Bostrom MP, Saleh KJ, Einhorn TA: Osteoinductive growth factors in preclinical fracture and long bone defects models. Orthop Clin North Am (1999) 30(4):647-658.
8. Lieberman JR, Daluiski A, Einhorn TA: The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am (2002) 84-A(6):1032-1044.
9. Wozney JM, Rosen V: Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop (1998) 346:26-37.
10. Hollinger JO, Schmitt JM, Buck DC, Shannon R, Joh SP, Zegzula HD, Wozney J: Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res (1998) 43(4):356-364.
11. Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS, Wozney JM: Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA (1988) 85(24):9484-9488.
12. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: Molecular clones and activities. Science (1988) 242(4885):1528-1534.
13. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA: The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am (1992) 74(5):659-670.
14. Ishaug-Riley SL, Crane GM, Gurlek A, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG: Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res (1997) 36(1):1-8.
15. Ripamonti U, Ma SS, van den Heever B, Reddi AH: Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. Plast Reconstr Surg (1992) 90(3):382-393.
16. Ripamonti U, Ramoshebi LN, Matsaba T, Tasker J, Crooks J, Teare J: Bone induction by BMPs/OPs and related family members in primates. J Bone Joint Surg Am (2001) 83-A(Suppl 1 Pt 2):S116-S127.
17. Boden SD, Zdeblick TA, Sandhu HS, Heim SE: The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report. Spine (2000) 25(3):376-381.
18. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S: Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am (2001) 83-A(Suppl 1 Pt 2):S151-S158.
19. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA: Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech (2002) 15(5):337-349.
20. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P et al: Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am (2002) 84-A(12):2123-2134.
21. Winn SR, Uludag H, Hollinger JO: Carrier systems for bone morphogenetic proteins. Clin Orthop (1999) 367(Suppl):S95- S106.
22. Ludwig SC, Boden SD: Osteoinductive bone graft substitutes for spinal fusion: A basic science summary. Orthop Clin North Am (1999) 30(4):635-645.
23. Perry CR: Bone repair techniques, bone graft, and bone graft substitutes. Clin Orthop (1999) 360:71-86.
24. Goshima J, Goldberg VM, Caplan AI: The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. Clin Orthop (1991) 269:274-283.
25. Green DW, Leveque I, Walsh D, Partridge KA, Mann S, Oreffo ROC: Innovative biomineralised polysaccharide templates for human bone cell and gene delivery. J Bone Miner Res (2003) 18(7):1361.
26. Pfeilschifter J, Wolf O, Naumann A, Minne HW, Mundy GR, Ziegler R: Chemotactic response of osteoblastlike cells to transforming growth factor β. J Bone Miner Res (1990) 5(8):825-830.
27. Pfeilschifter J, Diel I, Pilz U, Brunotte K, Naumann A, Ziegler R: Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age. J Bone Miner Res (1993) 8(6):707-717.
28. Pfeilschifter J, Mundy GR: Modulation of type β transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA (1987) 84(7):2024-2028.
29. Bonewald L: Transforming growth factor β. In: Principles of Bone Biology. Bilezikian JP, Raisz LG, Rodan GA (Eds), USA Academic Press, San Diego, CA, USA (2003) 1:903-918.
30. Marcelli C, Yates AJ, Mundy GR: In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice. J Bone Miner Res (1990) 5(10):1087-1096.
31. Noda M, Camilliere JJ: In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology (1989) 124(6):2991-2994.
32. Beck LS, Deguzman L, Lee WP, Xu Y, McFatridge LA, Gillett NA, Amento EP: TGF-β1 induces bone closure of skull defects. J Bone Miner Res (1991) 6(11):1257-1265.
33. Lind M, Schumacker B, Soballe K, Keller J, Melsen F, Bunger C: Transforming growth factor-β enhances fracture healing in rabbit tibiae. Acta Orthop Scand (1993) 64(5):553-556.
34. Critchlow MA, Bland YS, Ashhurst DE: The effect of exogenous transforming growth factor-β2 on healing fractures in the rabbit. Bone (1995) 16(5):521-527.
35. Reddi AH: Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr Opin Cell Biol (1992) 4(5):850-855.
36. Imai S, Kaksonen M, Raulo E, Kinnunen T, Fages C, Meng X, Lakso M, Rauvala H: Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J Cell Biol (1998) 143(4):1113-1128.
37. Merenmies J, Rauvala H: Molecular cloning of the 18-kDa growthassociated protein of developing brain . J Biol Chem (1990) 265(28):16721-16724.
38. Hampton BS, Marshak DR, Burgess WH: Structural and functional characterization of full-length heparin-binding growth associated molecule. Mol Biol Cell (1992) 3(1):85-93.
39. Deuel TF, Zhang N, Yeh HJ, Silos-Santiago I, Wang ZY: Pleiotrophin: A cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys (2002) 397(2):162-171.
40. Masuda H, Tsujimura A, Yoshioka M, Arai Y, Kuboki Y, Mukai T, Nakamura T, Tsuji H, Nakagawa M, Hashimoto-Gotoh T: Bone mass loss due to estrogen deficiency is compensated in transgenic mice overexpressing human osteoblast stimulating factor-1. Biochem Biophys Res Commun (1997) 238(2):528-533.
41. Tare RS, Rauvala H, Hashimoto-Gotoh T, Oreffo ROC, Clarke NMP, Roach HI: The roles of the osteoblast stimulating factor-1 during endochondral ossification. J Bone Miner Res (2001) 16(6):Abs 1178.
42. Yang X, Tare RS, Partridge KA, Roach HI, Clarke NM, Howdle SM, Shakesheff KM, Oreffo ROC: Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: Osteoconductive biomimetic scaffolds for tissue engineering. J Bone Miner Res (2003) 18(1):47-57.
43. Tare RS, Oreffo ROC, Clarke NM, Roach HI: Pleiotrophin/ osteoblaststimulating factor 1: Dissecting its diverse functions in bone formation. J Bone Miner Res (2002) 17(11):2009-2020.
44. Mohan S, Baylink DJ: Insulin-like growth factor system components and the coupling of bone formation to resorption. Horm Res (1996) 45(Suppl 1):59-62.
45. Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP: Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res (2002) 17(9):1570-1578.
46. Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA et al: Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation. Endocrinology (2000) 141(7):2674-2682.
47. Thaller SR, Salzhauer MA, Rubinstein AJ, Thion A, Tesluk H: Effect of insulin-like growth factor type I on critical size calvarial bone defects in irradiated rats. J Craniofac Surg (1998) 9(2):138-141.
48. Thaller SR, Lee TJ, Armstrong M, Tesluk H, Stern JS: Effect of insulinlike growth factor type 1 on critical-size defects in diabetic rats. J Craniofac Surg (1995) 6(3):218-223.
49. Thaller SR, Dart A, Tesluk H: The effects of insulin-like growth factor-1 on critical-size calvarial defects in Sprague-Dawley rats. Ann Plast Surg (1993) 31(5):429-433.
50. Raschke M, Wildemann B, Inden P, Bail H, Flyvbjerg A, Hoffmann J, Haas NP, Schmidmaier G: Insulin-like growth factor-1 and transforming growth factor-β1 accelerates osteotomy healing using polylactide-coated implants as a delivery system: A biomechanical and histological study in minipigs. Bone (2002) 30(1):144-151.
51. Schmidmaier G, Wildemann B, Gabelein T, Heeger J, Kandziora F, Haas NP, Raschke M: Synergistic effect of IGF-I and TGF-β1 on fracture healing in rats: Single versus combined application of IGF-I and TGF-β1. Acta Orthop Scand (2003) 74(5):604-610.
52. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM: Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest (2000) 105(8):1085-1093.
53. Inui K, Maeda M, Sano A, Fujioka K, Yutani Y, Sakawa A, Yamano Y, Kato Y, Koike T: Local application of basic fibroblast growth factor minipellet induces the healing of segmental bony defects in rabbits. Calcif Tissue Int (1998) 63(6):490-495.
54. Kato T, Kawaguchi H, Hanada K, Aoyama I, Hiyama Y, Nakamura T, Kuzutani K, Tamura M, Kurokawa T, Nakamura K: Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res (1998) 16(6):654-659.
55. Radomsky ML, Aufdemorte TB, Swain LD, Fox WC, Spiro RC, Poser JW: Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res (1999) 17(4):607-614.
56. Canalis E, Varghese S, McCarthy TL, Centrella M: Role of platelet derived growth factor in bone cell function. Growth Regul (1992) 2(4):151-155.
57. Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ: Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone (1994) 15(2):203-208.
58. Lynch SE, Buser D, Hernandez RA, Weber HP, Stich H, Fox CH, Williams RC: Effects of the platelet-derived growth factor/insulinlike growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J Periodontol (1991) 62(11):710- 716.
59. Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE: A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol (1997) 68(12):1186-1193.
60. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat Med (2003) 9(6):669-676.
61. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N: VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med (1999) 5(6):623-628.
62. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N et al: Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA (2002) 99(15):9656-9661.
63. Partridge KA, Oreffo ROC: Gene delivery in bone tissue engineering: Progress and prospects using viral and non-viral strategies. Tissue Eng (2004) 10(1-2):295-307.